Assay Designs Ann Arbor Mi
Lab Reagents
Human IgG antibody Laboratories manufactures the assay designs ann arbor mi reagents distributed by Genprice. The Assay Designs Ann Arbor Mi reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Arbor Assays. Other Assay products are available in stock. Specificity: Assay Category: Designs Group: Ann Arbor
Assay Buffer Concentrate, 55ML |
|||
X088-55ML | Arbor Assays | 55ML | EUR 171.6 |
Assay Buffer Concentrate, 25ML |
|||
X106-25ML | Arbor Assays | 25ML | EUR 130.8 |
Assay Buffer Concentrate, 28ML |
|||
X111-28ML | Arbor Assays | 28ML | EUR 147.6 |
Assay Buffer Concentrate, 28ML |
|||
X112-28ML | Arbor Assays | 28ML | EUR 147.6 |
Assay Buffer Concentrate, 25ML |
|||
X121-25ML | Arbor Assays | 25ML | EUR 130.8 |
Assay Buffer Concentrate, 28ML |
|||
X122-28ML | Arbor Assays | 28ML | EUR 147.6 |
Assay Buffer Concentrate, 28ML |
|||
X132-28ML | Arbor Assays | 28ML | EUR 147.6 |
MI-2 |
|||
A3602-10 | ApexBio | 10 mg | EUR 338.4 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-200 | ApexBio | 200 mg | EUR 1869.6 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-5 | ApexBio | 5 mg | EUR 254.4 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 498 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-2 |
|||
A3602-50 | ApexBio | 50 mg | EUR 756 |
Description: MI-2 is a Menin-MLL inhibitor with IC50 value of 0.45 ?M [1]. Mixed-lineage leukemia (MLL) is a common target of chromosomal translocations in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). |
MI-3 |
|||
A3603-10 | ApexBio | 10 mg | EUR 480 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-100 | ApexBio | 100 mg | EUR 1863.6 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-5 | ApexBio | 5 mg | EUR 320.4 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 370.8 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |
MI-3 |
|||
A3603-50 | ApexBio | 50 mg | EUR 1461.6 |
Description: MI-3 is an inhibitor of Menin-Mixed linage leukemia (MML) protein interaction with IC50 value of 648 ± 25 nM [1].MLL protein is a histone methyltransferase that positively regulates gene transcription. |